ALIVE Charity Foundation donated €80,000 to the Research Trust of the University of Malta (RIDT) to further the University of Malta specialised programme in breast cancer research. The generous sum was collected by ALIVE cyclists who bravely ventured into the Malta Airport – ALIVE2014 Cycling Challenge for Cancer – a gruelling marathon covering almost 1,100 km in seven days across five countries from Prague to Belgrade
Mr Nicky Camilleri said: “ALIVE2014 was another successful event during which 45 cyclists raised funds for breast cancer research in Malta. For two consecutive years, we have worked closely with two organisations: Action for Breast Cancer Foundation and Europe Donna, and through ALIVE2013 University graduate Shawn Baldacchino was awarded a 3-year scholarship in PhD in breast cancer research. In the coming weeks, more scholarships will be awarded in this field, thanks to the funds raised this year.”
The money will benefit mainly a second PhD science student in breast cancer research under the tutorship of Professor Christian Scerri and Dr Godfrey Grech at the University of Malta and in collaboration with Mater Dei Hospital.
On receiving the donation, Professor Camilleri said: “Investing in research is a long-term mission. With this money, the University is able to sustain further crucial scientific research in breast cancer. We depend on the generosity of the Maltese community and it is encouraging to note that the University Research Trust is now being recognised as a good cause that deserves support.”
Malta International Airport’s Chief Executive Officer Markus Klaushofer said: “We would like to congratulate the ALIVE organisational team and participants for yet another successful challenge and for the fantastic result they have achieved. On a personal level, it was a real thrill to join the cyclists for one of the rides from Vienna, and really experience the challenge first hand, with my Maltese friends in my home town. We encourage ALIVE to continue to build on these initiatives which drive awareness and stimulate scientific research in the field, which will meaningfully impact the quality of life of cancer patients.”
